Spyre Therapeutics Inc (SYRE.O)

+ 收藏

财务摘要(报告期)(Spyre Therapeutics Inc)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2025年中报2025年一季报2024年年报2024年三季报2024年中报2024年一季报
每股指标:
 每股收益EPS基本(元) 会员可见会员可见会员可见会员可见-2.02-1.20
 每股净资产(元) 会员可见会员可见会员可见会员可见7.3711.08
 每股经营现金净流量(元) 会员可见会员可见会员可见会员可见-1.79-0.78
 每股现金流量净额(元) 会员可见会员可见会员可见会员可见-2.831.06
盈利能力:
 净资产收益率平均(%) 会员可见会员可见会员可见会员可见-25.72-13.01
 总资产净利率(%) 会员可见会员可见会员可见会员可见-21.26-10.57
 投入资本回报率ROIC(%) 会员可见会员可见会员可见会员可见-30.41-21.24
收益质量:
 营业利润/利润总额(%) 会员可见会员可见会员可见会员可见111.20109.01
资本结构:
 资产负债率(%) 会员可见会员可见会员可见会员可见14.1516.80
 权益乘数 会员可见会员可见会员可见会员可见1.161.20
 产权比率 会员可见会员可见会员可见会员可见0.160.20
 流动资产/总资产(%) 会员可见会员可见会员可见会员可见99.9299.93
 非流动资产/总资产(%) ----0.080.07
 流动负债/负债合计(%) 会员可见会员可见会员可见会员可见35.8652.26
 非流动负债/负债合计(%) -会员可见会员可见会员可见64.1447.74
 归属母公司股东的权益/投入资本(%) 会员可见会员可见会员可见会员可见95.77156.00
偿债能力:
 流动比率 会员可见会员可见会员可见会员可见19.7011.38
 速动比率 会员可见会员可见会员可见会员可见19.7011.38
 货币资金/流动负债(%) 会员可见会员可见会员可见会员可见204.07531.44
 营业利润/流动负债(%) 会员可见会员可见会员可见会员可见-415.52-111.57
 经营活动产生的现金流量净额/流动负债(%) 会员可见会员可见会员可见会员可见-410.41-66.66
 归属母公司股东的权益/负债合计(%) 会员可见会员可见会员可见会员可见606.96495.16
 经营活动产生的现金流量净额/负债合计(%) 会员可见会员可见会员可见会员可见-147.19-34.84
 营业利润/负债合计(%) 会员可见会员可见会员可见会员可见-149.02-58.31
成长能力:
 总资产同比增长率(%) 会员可见会员可见会员可见会员可见79.06829.60
 每股净资产同比增长率(%) 会员可见会员可见会员可见会员可见6,044.262,052.18
 总负债同比增长率(%) 会员可见会员可见会员可见会员可见-75.68335.76
 基本每股收益同比增长率(%) 会员可见会员可见会员可见会员可见96.7475.46
 归属母公司股东的权益同比增长率(%) 会员可见会员可见会员可见会员可见3,826.711,105.50
 营业利润同比增长率(%) 会员可见会员可见会员可见会员可见48.37-154.04
 营业收入同比增长率(%) --会员可见会员可见-100.00-100.00
 股东权益合计同比增长率(%) 会员可见会员可见会员可见会员可见3,826.711,105.50
营运能力:
衍生指标:
 现金及现金等价物净增加额TTM(元) 会员可见会员可见会员可见会员可见-191,210,000.00191,318,000.00
 利润总额TTM(元) 会员可见会员可见会员可见会员可见-185,946,000.00-364,183,000.00
 毛利TTM(元) ---会员可见886,000.00886,000.00
 投入资本(元) 会员可见会员可见会员可见会员可见390,923,000.00260,050,000.00
 经营活动产生的现金流量净额TTM(元) 会员可见会员可见会员可见会员可见-156,423,000.00-110,818,000.00
 总营业收入TTM(元) ---会员可见886,000.00886,000.00
 归属母公司净利润TTM(元) 会员可见会员可见会员可见会员可见-185,981,000.00-364,225,000.00
 所得税TTM(元) 会员可见会员可见会员可见会员可见35,000.0042,000.00

前瞻产业研究院